Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dyadic Dynamics
Jupiter, Florida, United Statespmc.ncbi.nlm.nih.gov ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Dyadic International is a global biotechnology company specializing in microbial platforms for efficient large-scale manufacture of proteins used in human and animal vaccines, therapeutics, and non-pharmaceutical applications. Its proprietary C1 gene expression system enables rapid production of biologics at lower cost. The company has demonstrated revenue growth through milestone payments from its alternative protein segment and expects to launch Human Serum Albumin commercially in 2025. It has received significant grant funding from CEPI and the Gates Foundation validating its technology's potential for vaccine/antibody manufacturing scalability.
- Therapeutic areas
- Metabolic DisordersInfectious DiseasesOther
- Modalities
- Recombinant proteinMonoclonal antibodyVaccineEnzyme replacement therapyFc-fusion proteinBispecific monoclonal antibody
- Industry
- Biotech
02
Partnerships
CEPI (Coalition for Epidemic Preparedness Innovations)Bill & Melinda Gates FoundationWHO consultation participant on mAb manufacturing technologiesBDI Holdings/VLPbio R&D partnershipsMultiple undisclosed biopharma/bioindustrial companies globally
Beyond the preview
Go deeper on Dyadic Dynamics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dyadic Dynamics.